Kroese, Tiuri E;
Bronzwaer, Sebastiaan;
van Rossum, Peter S. N;
Schoppman, Sebastian F;
Deseyne, Pieter R. A. J;
van Cutsem, Eric;
Haustermans, Karin;
Nafteux, Philippe;
Thomas, Melissa;
Obermannova, Radka;
Mortensen, Hanna R;
Nordsmark, Marianne;
Pfeiffer, Per;
Elme, Anneli;
Adenis, Antoine;
Piessen, Guillaume;
Bruns, Christiane J;
Lordick, Florian;
Gockel, Ines;
Moehler, Markus;
Gani, Cihan;
Liakakos, Theodore;
Reynolds, John V;
Morganti, Alessio G;
Rosati, Riccardo;
Castoro, Carlo;
Cellini, Francesco;
D'Ugo, Domenico;
Roviello, Franco;
Bencivenga, Maria;
Manzoni, Giovanni de;
van Berge Henegouwen, Mark I;
Hulshof, Maarten C. C. M;
van Dieren, Jolanda;
Vollebergh, Marieke;
van Sandick, Johanna W;
Jeene, Paul;
Muijs, Christel;
Slingerland, Marije;
Voncken, Francine E. M;
Hartgrink, Henk;
Creemers, Geert-Jan;
van der Sangen, Maurice J. C;
Nieuwenhuijzen, Grard A. P;
Berbee, Maaike;
Verheij, Marcel;
Wijnhoven, Bas;
Beerepoot, Laurens V;
Mohammad, Nadia Haj;
Mook, Stella;
Ruurda, Jelle P;
Kolodziejczyk, Piotr;
Polkowski, Wojciech P;
Wyrwicz, Lucjan;
Alsina, Maria;
Tabernero, Josep;
Per, Manuel;
Kanonnikoff, Tania F;
Cervantes, Andrés;
Nilsson, Magnus;
Monig, Stefan;
Wagner, Anna D;
Guckenberger, Matthias;
Griffiths, Ewen A;
Smyth, Elizabeth;
Hanna, George B;
Markar, Sheraz;
Chaudry, M. Asif;
Hawkins, Maria A;
Cheong, Edward;
van Laarhoven, Hanneke W. M;
van Hillegersberg, Richard.
The OligoMetastatic Esophagogastric Cancer (OMEC) project aims to provide clinical practice guidelines for the definition, diagnosis, and treatment of esophagogastric oligometastatic disease (OMD).
Guidelines were developed according to AGREE II and GRADE principles. Guidelines were based on a systematic...
McLornan, Donal P;
Psaila, Bethan;
Ewing, Joanne;
Innes, Andrew;
Arami, Siamak;
Brady, Jessica;
Butt, Nauman M;
Cargo, Catherine;
Cross, Nicholas C. P;
Francis, Sebastian;
Frewin, Rebecca;
Garg, Mamta;
Godfrey, Anna L;
Green, Anna;
Khan, Alesia;
Knapper, Steve;
Lambert, Jonathan;
McGregor, Andrew;
McMullin, Mary Frances;
Nangalia, Jyoti;
Neelakantan, Pratap;
Woodley, Claire;
Mead, Adam;
Somervaille, Tim C. P;
Harrison, Claire N.
This document represents an update of the British Society for Haematology guideline on Myelofibrosis first published in 2012 and updated in 2015 These guidelines aim to pro-vide healthcare professionals with clear guidance on stratified management for primary myelofibrosis (PMF)...
El cáncer de próstata metastásico se presenta en el 20% de pacientes al momento del
diagnóstico de cáncer de próstata (1). Los sitios comunes de diseminación metastásica
locorregional son los ganglios linfáticos (99%) y huesos como pelvis, cadera y esqueleto axial
(84%); mientras que las localiz...
Evidence-based recommendations on olaparib (Lynparza) for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer in adults.
Commercial arrangement
There is a simple discount patient access scheme for olaparib. NHS organisations can get details on the Commercial Access and ...
NICE is unable to make a recommendation on capmatinib (Tabrecta) for treating advanced non-small-cell lung cancer with MET exon 14 skipping in adults. This is because Novartis Pharmaceuticals did not provide an evidence submission. We will review this decision if the company decides to make a submission....
Evidence-based recommendations on lenvatinib (Kisplyx) with pembrolizumab (Keytruda) for untreated advanced renal cell carcinoma in adults.
Commercial arrangements
There is a simple discount patient access scheme for lenvatinib and a commercial access agreement for pembrolizumab. NHS organisations can g...
This guideline covers managing colorectal (bowel) cancer in people aged 18 and over. It aims to
improve quality of life and survival for adults with colorectal cancer through management of local
disease and secondary tumours (metastatic disease).
The recommendations in this guideline were developed befor...
La incidencia del carcinoma de células renales (CCR) ha aumentado en las últimas décadas, siendo a nivel mundial
el sexto cáncer más frecuentemente diagnosticado en hombres y el décimo en mujeres (1). Sin embargo, la
sobrevida ha mejorado en las últimas tres décadas. Esto se ha dado, en parte, po...
The purpose of this guideline is to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match the capacity for cancer treatment to patient needs if services become limited because of the COVID-19 pandem...
This guideline covers managing colorectal (bowel) cancer in people aged 18 and over. It aims to improve quality of life and survival for adults with colorectal cancer through management of local disease and management of secondary tumours (metastatic disease)....
